Cargando…
Can synthetic data be a proxy for real clinical trial data? A validation study
OBJECTIVES: There are increasing requirements to make research data, especially clinical trial data, more broadly available for secondary analyses. However, data availability remains a challenge due to complex privacy requirements. This challenge can potentially be addressed using synthetic data. SE...
Autores principales: | Azizi, Zahra, Zheng, Chaoyi, Mosquera, Lucy, Pilote, Louise, El Emam, Khaled |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055130/ https://www.ncbi.nlm.nih.gov/pubmed/33863713 http://dx.doi.org/10.1136/bmjopen-2020-043497 |
Ejemplares similares
-
Validating a membership disclosure metric for synthetic health data
por: El Emam, Khaled, et al.
Publicado: (2022) -
Optimizing the synthesis of clinical trial data using sequential trees
por: Emam, Khaled El, et al.
Publicado: (2020) -
Evaluating Identity Disclosure Risk in Fully Synthetic Health Data: Model Development and Validation
por: El Emam, Khaled, et al.
Publicado: (2020) -
Utility Metrics for Evaluating Synthetic Health Data Generation Methods: Validation Study
por: El Emam, Khaled, et al.
Publicado: (2022) -
Validation of ethnicity in administrative hospital data in women giving birth in England: cohort study
por: Jardine, Jennifer Elizabeth, et al.
Publicado: (2021)